Skip to main content
Log in

Alternative mydriasis techniques for retinopathy of prematurity screening

  • Review
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

There is a large variation in mydriatic regimens used in screening for retinopathy in preterm infants. Except for the standard instillation of mydriatic drops in their commercial formulation, other techniques for pupil dilation have also been described. This study aimed to review all techniques that have been used for mydriasis in retinopathy of prematurity eye examination (ROPEE) screening.

Methods

A comprehensive literature search was performed in PubMed, Cochrane library, Trip database, and Scopus, using the key words: “mydriasis”, “techniques”, “mydriatics”, “dilating drops”, “retinopathy of prematurity”, “ROP”, “phenylephrine”, “cyclopentolate”, “tropicamide”, “smaller mydriatic drops”, “reduction in drop size” to February 2019.

Results

Five primary studies were included, assessing the techniques of microdrops, lower conjunctival fornix (LCF) packing and Mydriasert® ophthalmic insert. Reported efficacy was similar to commercial eyedrops instillation. Microdrops appeared to have a superior safety profile. LCF packing and Mydriasert lead to increased blood pressure, without serious complications, necessitating further safety studies.

Conclusions

Of all alternative mydriasis techniques for ROPEE screening that have been described, microdrops appear to be the safest yet still effective technique in the fragile population of premature infants in risk of ROP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Availability of data and materials

Not applicable.

References

  1. Kremer LJ, Reith DM, Medlicott N, Broadbent R (2019) Systematic review of mydriatics used for screening of retinopathy in premature infants. BMJ Paediatr Open 3(1):e000448. https://doi.org/10.1136/bmjpo-2019-000448

    Article  PubMed  PubMed Central  Google Scholar 

  2. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD et al (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https://doi.org/10.1136/bmj.d5928

    Article  PubMed  PubMed Central  Google Scholar 

  3. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M et al (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute Web site. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 20 Aug 2019

  4. Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Son F et al (2003) Evaluating non-randomised intervention studies. Health Technol Assess 7(27):1–173. https://doi.org/10.3310/hta7270

    Article  Google Scholar 

  5. Lynch MG, Brown RH, Goode SM, Schoenwald RD, Chien S (1987) Reduction of phenylephrine drop size in infants achieves equal dilation with decreased systemic absorption. Arch Ophthalmol 105(10):1364–1365. https://doi.org/10.1001/archopht.1987.01060100066027

    Article  CAS  PubMed  Google Scholar 

  6. Wheatcroft S, Sharma A, McAllister J (1993) Reduction in mydriatic drop size in premature infants. Br J Ophthalmol 77(6):364–365. https://doi.org/10.1136/bjo.77.6.364

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Elibol O, Alçe T, Yüksel N, Çaĝlar Y (1997) The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants. Acta Ophthalmol Scand 75(2):178–180. https://doi.org/10.1111/j.1600-0420.1997.tb00119.x

    Article  CAS  PubMed  Google Scholar 

  8. Thanathanee O, Ratanapakorn T, Morley MG, Yospaiboon Y (2012) Lower conjunctival fornix packing for mydriasis in premature infants: a randomized trial. Clin Ophthalmol 6:253–256. https://doi.org/10.2147/OPTH.S28714

    Article  PubMed  PubMed Central  Google Scholar 

  9. Bremond-Gignac D, Jacqz-Aigrain E, Abdoul H, Daruich A, Beresniak A, Baud O, Alberti C (2019) Ophthalmic insert versus eye drops for mydriasis in neonates: a randomized clinical trial. Neonatology 115(2):142–148. https://doi.org/10.1159/000493723

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The authors received no financial support for this submission.

Author information

Authors and Affiliations

Authors

Contributions

All authors have made substantive intellectual contributions to this study. All authors (AKS, EP, ML, SK, NZ, VS and AM) contributed to the conceptualization of the manuscript, overview of literature and interpretation of data. AKS and AM contributed to the design of this work. AKS, AM, EP and ML contributed to data acquisition and extraction. AKS, AM, EP prepared the draft manuscript of this review. EP, AKS, AM prepared the methodological quality assessment. All authors reviewed and approved the final version of the manuscript.

Corresponding author

Correspondence to Asimina Mataftsi.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Ethical approval

Not applicable.

Code availability

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seliniotaki, A.K., Prousali, E., Lithoxopoulou, M. et al. Alternative mydriasis techniques for retinopathy of prematurity screening. Int Ophthalmol 40, 3613–3619 (2020). https://doi.org/10.1007/s10792-020-01542-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-020-01542-x

Keywords

Navigation